Upregulation of LOXL1-AS1 has also been observed in cholangiocarcinoma (CCA) and has been associated with lymph node invasion, advanced disease stages, increased cell proliferation, enhanced cell migration, and attenuation of apoptosis (37). This evidence concerns the gene LOXL1 and cholangiocarcinoma.